Innovation Pharmaceuticals Inc (IPIX)

[MinnieM]

Brilacidin has passed safety benchmarks in multiple clinical trials and, is currently being tested as a covid therapeutic in two US RBL’s.

Brilacidin for ABSSSI is ph3 ready. Ph2 was dosed via IV in hundreds of patients.

Brilacidin for OM is ph3 ready. Ph2 was dosed via swish and spit.

Brilacidin for UP ph 2 POC trial was dosed with water enema. Results good enough that Alfasigma licensed Brilacidin for UP dosing with foam, enema, or gel.

Brilacidin for UC ph 1 was dosed with Oralogic tablet.






Message in reply to:

I’m in a slight disagreement with a scientist on Twitter. Can anyone tell me how many FDA trials for Brilacidin have used human subjects? He claims only OM is the only trial.